IVIVR in oral absorption for fenofibrate immediate release tablets using dissolution and dissolution permeation methods

Pharmazie

Volumn 65, Issue 10, 2010, Pages 723-728

  Buch, P ^a   Holm, P ^b   Thomassen, J Q ^b   Scherer, D ^c   Kataoka, M ^d   Yamashita, S ^d   Langguth, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b LifeCycle Pharma   (Denmark)

^c ApisPharma ^*  (Switzerland)

^d SETSUNAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; SURFACTANT;

ADULT; AGED; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DRUG ABSORPTION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN;

ADULT; AGED; AREA UNDER CURVE; CACO-2 CELLS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FENOFIBRATE; HALF-LIFE; HUMANS; HYPOLIPIDEMIC AGENTS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 78349294519     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0114     Document Type: Article

References (24)

1. Artursson P, Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175: 880-885.
2. Bennion BC, Tong LKJ, Holmes LP, Eyring EM (1969) Kinetics of sodium lauryl sulfate micelle dissociation by a light-scattering temperature-jump technique. J Phys Chem 73: 3288-3289.
3. Buch P, Langguth P, Kataoka M, Yamashita S (2009) IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/ permeation system. J Pharm Sci 98: 2001-2009.
4. Busoi C, Rotaru M, Oghina B, Surmeian M (2006) Method of Purifying a Surfactant by Ultrafiltration. WO/2006/084902.
5. Dressman JB, Amidon GL, Reppas C, Shah VP (1998). Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 15: 11-22. (Pubitemid 28080861)
6. Galia E, Nicolaides E, Horter D, Lobenberg R, Reppas C, Dressman JB (1998) Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 15: 698-705. (Pubitemid 28275645)
7. Ginski MJ, Taneja R, Polli JE (1999) Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system. AAPS PharmSci 1: E3.
8. Granero GE, Ramachandran C, Amidon GL (2005) Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev Ind Pharm 31: 917-922. (Pubitemid 41540944)
9. Holm P, Norling T (2007) A tablet comprising a fibrate;WO/2006/084475.
10. Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR (1999) MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J Pharm Sci 88: 28-33. (Pubitemid 29037364)
11. Kataoka M, Masaoka Y, Yamazaki Y, Sakane T, Sezaki H, Yamashita S (2003) In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs. Pharm Res 20: 1674-1680.
12. Kataoka M, MasaokaY, Sakuma S,Yamashita S (2006) Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system. J Pharm Sci 95: 2051-2061. (Pubitemid 44433034)
13. Kesisoglou F, Panmai S,WuY(2007) Nanosizing-Oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59: 631-644. (Pubitemid 47285408)
14. Kobayashi M, Sada N, Sugawara M, Iseki K, Miyazaki K (2001) Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. Int J Pharm 221: 87-94. (Pubitemid 32524038)
15. Lobenberg R, Kramer J, Shah VP, Amidon GL, Dressman JB (2000) Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide. Pharm Res 17: 439-444. (Pubitemid 30395299)
16. Patel N, Forbes B, Eskola S, Murray J (2006) Use of Simulated Intestinal Fluids with Caco-2 Cells and Rat Ileum. Drug Dev Ind Pharm 32: 151-161.
17. Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simon-Assmann P, Haffen K, Fogh J (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47: 323-330. (Pubitemid 14236699)
18. Ryde T, GustowEE, Ruddy SB, Jain R, Patel R,WilkinsMJ(2007) Nanoparticulate fibrate formulations. US Patent 7,276,249.
19. Schiller C, Frohlich CP, Giessmann T, Siegmund W, Monnikes H, Hosten N, Weitschies W (2005) Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 22: 971-979. (Pubitemid 41634879)
20. Serbest G, Horwitz J, Barbee K (2005) The effect of poloxamer-188 on neuronal cell recovery from mechanical injury. J Neurotrauma 22: 119-132.
21. ShahVP, Hunt JP, FairweatherWR,Prasad VK, KnappG(1986) Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline. Biopharm Drug Dispos 7: 27-33.
22. Wanka G, Hoffmann H, UlbrichtW(1994) Phase diagrams and aggregation behavior of poly (oxyethylene)-poly (oxypropylene)-poly (oxyethylene) triblock copolymers in aqueous solutions. Macromolecules 27: 4145-4159.
23. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4: 879-885. (Pubitemid 12174128)
24. Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10: 195-204 (Pubitemid 30190095)